CLBT · Cellebrite DI Ltd.

Cellebrite's Q1 2026 results demonstrated robust growth with revenue increasing 19% year-over-year to $128.3 million, driven primarily by subscription revenue up 23% to $117.9 million, reflecting strong demand for its AI-powered digital investigative solutions. ARR expanded 21% to $493.0 million, supported by a 115% dollar-based net retention rate, indicating effective customer expansion and retention. Gross margins remained strong at 82.5% GAAP and 85.9% non-GAAP, while profitability metrics showed GAAP net income of $10.9 million and non-GAAP net income of $30.6 million, with Adjusted EBITDA at 23.9% margin. CEO Thomas E. Hogan highlighted the positive customer response to new offerings like Guardian Investigate, Genesis, advanced unlock, and drone forensics, positioning the company for ARR acceleration in Q2. The acquisition of SCG Canada on March 1 broadened drone forensics capabilities, targeting growth in defense, intelligence, and law enforcement sectors. Guidance signals confidence with Q2 ARR expected at $510-$513 million (22-23% growth) and full-year revenue at $565-$571 million (19-20% growth), alongside expanding Adjusted EBITDA margins to 26-27%. TTM free cash flow of $158.6 million (32% margin) underscores healthy cash generation. Innovations such as Cellebrite Genesis in beta, Guardian Investigate general availability, and Spring 2026 Release with iPhone 17 support, plus FedRAMP High Authorization for Government Cloud, enhance competitive positioning and go-to-market momentum as evidenced by the C2C User Summit.